Evaluation of [18F]APN-1607 as a PET Biomarker
NCT05005819
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Progressive Supranuclear Palsy
Healthy Volunteers
Interventions
DRUG:
[18F] APN-1607
Sponsor
Invicro